Gilles Amsallem

Part of Teva Pharmaceutical Industries Ltd., Mixis Genetics Ltd is a French company that develops medicinal chemicals and botanical products. The company is based in Paris, France. The CEO of the company is Gilles Amsallem. Mixis Genetics was acquired by PLIVA dd, part of Teva Pharmaceutical Industries Ltd. from October 24, 2006 on April 01, 1999 for $3.26 million.

Snia SpA is an industrial group with operations in the special textile filaments, fine chemicals and real estate markets. The company was founded in July 18, 1917 and is headquartered in Milan, Italy

Sorin Biomedica Cardio France SA wholesales & distributes pharmaceutical products. The company was founded in 1987 and is headquartered in Meudon, France.

DuPont de Nemours (France) SAS manufactures chemical products. The company is headquartered in Puteaux, France.

Biométhodes SA develops a technology in engineering and optimization of enzymes. It offers chemical pretreatment of non-food biomass and bio-refinery process. The company was founded in 1997 and is headquartered in Evry, France.

Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India.